Preferences of pregnant women toward a future maternal Group B Streptococcus vaccine in China: A cross-sectional survey with a discrete choice experiment

Hum Vaccin Immunother. 2023 Dec 15;19(3):2281713. doi: 10.1080/21645515.2023.2281713. Epub 2023 Nov 21.

Abstract

Group B streptococcus (GBS) is a major cause of neonatal death worldwide. A GBS vaccine for pregnant women is under development and is expected to be available in the near future. The perceptions and preferences of pregnant women in China of GBS vaccines has not been investigated, and this study aimed to investigate pregnant women's awareness of GBS and their potential preferences for the GBS vaccine. A discrete choice experiment was conducted among pregnant women in hospitals from Shaanxi, Hunan, and Zhejiang provinces located in Western, Central, and Eastern China, respectively. A conditional logit model was used to analyze the data and calculate willingness to pay values and choice probabilities of different GBS vaccine programs. A total of 354 pregnant women were included in the final analysis, 45.8% of whom were willing to receive a GBS vaccine if it were licensed. Vaccine safety was the most important attribute of a future vaccine, while cost was the least important attribute. Compared with no vaccination, pregnant women had a strong preference for future GBS vaccination (ASC = 1.267, p < .001). Pregnant women's decisions were highly influenced by those of other pregnant women. Improving the safety, efficacy, and vaccination rate of the GBS vaccine in China is of great significance for future GBS vaccine development and vaccination. Compared to other variable options, the cost of a GBS vaccine was of the least importance among pregnant women in mainland China. These findings can inform public health policy decisions related to GBS vaccination in China.

Keywords: Group B Streptococcus; discrete choice experiment; preference; pregnant women; vaccine.

MeSH terms

  • China
  • Cross-Sectional Studies
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnant Women
  • Streptococcal Infections* / prevention & control
  • Streptococcal Vaccines*
  • Streptococcus agalactiae
  • Vaccination

Substances

  • Streptococcal Vaccines

Grants and funding

The work was funded by the National Natural Science Foundation of China [grant number 82204109], China Postdoctoral Science Foundation [grant number 2020M673427] and the Key Research and Development Plan of Shaanxi Province [grant number 2022SF-106]. All funders have no role in the study design, data collection and analysis, manuscript writing, and the decision to submit the manuscript for publication.